SCTC Working Group Grant Awards

The RFA for the 2021 Working Group Grant is now available!

2020 SCTC Working Group Grant Awardees

Congratulations to the 2020 SCTC Working Group Grant Awardees!

"Evaluating the Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-Induced Osteoclast Activity in the Pathogenesis of Calcinosis in Systemic Sclerosis"

Primary Investigators:
Antonia Valenzuela, MD, MS
Claudia Huerta Calderon


"Development of SCTC Classification Criteria of Systemic Sclerosis Heart Involvement Using Consensus and Multi-Criteria Decision Analysis Methods"

Primary Investigators:
Mandana Nikpour, MBBS, FRACP, FRCPA, PhD
Murray Baron, BBS, MDCM, FRCP(C)
Alessandra Vacca, MD
Laura Ross, MBBS, FRACP


"Development of Preliminary Classification Criteria for Scleroderma Renal Crisis"

Primary Investigators:
Marie Hudson, MD, MPH
Christopher Denton, MD, PhD


 

Previous Years

Awards 2019

"Evaluating the Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-Induced Osteoclast Activity in the Pathogenesis of Calcinosis in Systemic Sclerosis"

Primary Investigator:
Antonia Valenzuela MD, MS


"Synchronizing Systemic Sclerosis Skin Gene Expression and Histology Data with a Machine Learning Approach"

Primary Investigator:
Kimberly Showalter, MD


"Development of Preliminary Classification Criteria for Scleroderma Renal Crisis"

Primary Investigators:
Marie Hudson, MD MPH and Christopher Denton, MD PhD


"Development of a Novel Patient-Reported Outcome Instrument for the Assessment of Digital Ulcers in Systemic Sclerosis"

Primary Investigators:
Michael Hughes, PhD MRCP

John Pauling, PhD FRCP

Awards 2018

"Development of a Preliminary Definition of Systemic Sclerosis Heart Involvement"

Primary Investigators:
Mandana Nikpour, MBBS, FRACP, FRCPA, PhD
Murray Baron, BBS, MDCM, FRCP(C)
Dr. Alessandra Vacca


"Plasma Inorganic Pyrophosphate (PPi) Levels as a Biomarker for Ectopic Calcification in Scleroderma Spectrum and Other Rheumatic Diseases"

Primary Investigators:
Dr. Vivien Hsu
Dr. John Varga


"Development and Validation of a Novel Patient-Derived Patient-Reported Outcome Instrument for Assessing the Activity and Impact of Raynaud's Phenomenon in Systemic Sclerosis"

Primary Investigators:
John Pauling, BMedSci, BMBS, PhD, FRCP
Robyn T. Domsic, MD, MPH
Dinesh Khanna, MD, MS

Awards 2017

"Development of a Consensus Definition for Scleroderma Renal Crisis (SRC)"

Primary Investigators:
Marie Hudson, MD, MPH
Christopher Denton, MD, PhD


"A Prospective Study to Identify Risk Factors for Progressive Calcinosis in Patients with Systemic Sclerosis: A Scleroderma Clinical Trials Consortium Study"

Primary Investigator:
Lorinda Chung, MD, MS


"Development of a Conceptual Framework for a Novel Patient-Reported Outcome Instrument for the Assessment of Digital Ulcers in Systemic Sclerosis"

Primary Investigators:
Michael Hughes, PhD, MRCP
John Pauling, PhD, FRCP


"The SCTC Damage Index: External Validation in the Canadian Scleroderma Research Group (CSRG) Cohort and Prospective Validation in the INternational SYstemic Sclerosis INception Cohort (INSYNC)"

Primary Investigators:
Mandana Nikpour, MB BS, FRACP, FRCPA, PhD
Murray Baron, BSc, MDCM, FRCP(C)

Pay Membership Fees

If you are a newly accepted member of the SCTC, please select Initial Fee at $250.00 USD.
If you are a returning member of the SCTC, please select the option of Annual Fee at $200.00 USD.
If your institution is unable to use PayPal, please contact admin@sclerodermaclinicaltrials.org.

Membership Fees



© 2021 Scleroderma Clinical Trials Consortium. Designed By Kangablu Ltd